Total Funding
34
45
Total FundingPost-IPO Equity raised
Growth Score 34 in past quarter
-3 pts
Heat Score 45 in past quarter
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
180069
ABVC Biopharma is a clinical-stage biopharmaceutical company that identifies drugs and medical devices under development.
- Uttam Yashwant Patil: Chief Executive Officer
About the Company
ABVC Biopharma is a clinical-stage biopharmaceutical company that identifies drugs and medical devices under development. For its drug products, the company is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. It specializes in botanically-based solutions that
deliver high efficacy with low toxicity for improved health outcomes.